The benefits of medical AI assistance vary based on user expertise
Study finds non-experts deferred to LLM-based diagnostic assistance, even when it was wrong, while clinicians caught AI errors.
Study finds non-experts deferred to LLM-based diagnostic assistance, even when it was wrong, while clinicians caught AI errors.
The visionary PhysioNet platform launched 25 years ago, based on a system developed at MIT in the 1970s. It has become one of the most comprehensive biomedical and clinical data repositories in existence.
Researchers developed an optical nanosensor to rapidly detect a key gut biomarker, enabling faster, accessible screening.
The new design could offer a surgery-free alternative to traditional cardiac implants.
At the 25th IDEAS Social Innovation Incubator Showcase and Awards, 21 student-led ventures joined 1,200 alumni-led ventures tackling the world’s most pressing problems through social entrepreneurship.
Nearly 100 MIT students participate in a buddy program that assists Boston-area residents.
Founded by Jake Donoghue PhD ’19 and former MIT researcher Jarrett Revels, the company is creating an AI-driven platform to help diagnose and treat disease.
Economists find that in metro areas with more immigration, nurses are spending more time with elderly patients.
MIT researchers leveraged a surprise discovery to devise a faster and more precise biomedical imaging technique.
Ultra-efficient chip design enables extremely strong cryptography algorithms to run on energy-constrained edge devices.
An MIT-led team is designing artificial intelligence systems for medical diagnosis that are more collaborative and forthcoming about uncertainty.
Anthropologist Amy Moran-Thomas studies overlooked insights from people health care is meant to reach.
MIT senior Srihitha Dasari reflects on the power of experiential learning through the PKG Center for Social Impact.
The technology could enable fast, point-of-care diagnoses for pneumonia and other lung conditions.
By showing the problem derives from genetic mutations that lead to overexpression of a microRNA, MIT researchers’ study points to potential treatment.